Introduction Ticagrelor is an oral antiplatelet agent used in the management of acute coronary syndrome (ACS) and for secondary prevention of thrombotic events. It directly and reversibly inhibits the P2Y₁₂ receptor on platelets, thereby preventing ADP-induced platelet aggregation. Unlike thienopyridines like clopidogrel, it does not require metabolic activation, leading to a faster and more predictable … Read more
Introduction Vyvanse (lisdexamfetamine) is a central nervous system stimulant used to treat ADHD and binge-eating disorder. It is a prodrug, meaning it becomes active only after enzymatic conversion in the body. This mechanism provides a smoother onset, extended action, and lower risk of misuse. Its active metabolite, dextroamphetamine, boosts dopamine and norepinephrine in the brain—improving … Read more
Introduction Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist used for sedation in intensive care settings and during surgical procedures. It provides sedation without significant respiratory depression, distinguishing it from other sedatives like benzodiazepines and propofol. Its analgesic-sparing and sympatholytic effects further enhance its clinical utility. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value … Read more
Introduction Apixaban is a direct oral anticoagulant (DOAC) used to prevent and treat thrombosis. It is specifically indicated for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of venous thromboembolism (VTE), and management of deep vein thrombosis (DVT) and pulmonary embolism (PE). Its predictable pharmacokinetics and oral administration make it a widely used alternative … Read more
